glioma, malignant
Showing 1 - 25 of 49
AI R&D Tool in Adult Glioma and Other Primary Brain Tumours
Not yet recruiting
- Brain Tumor
- +4 more
- Resection
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)
Active, not recruiting
- Glioma, Malignant
- Computer-Assisted
- Validation of IDH1 mutations from the radiomics model
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Jul 23, 2023
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Glioma, Malignant, Glioma Glioblastoma Multiforme Trial in Warsaw ([68Ga]Ga-PSMA-11 PET/CT)
Completed
- Glioma, Malignant
- Glioma Glioblastoma Multiforme
- [68Ga]Ga-PSMA-11 PET/CT
-
Warsaw, Mazowieckie, PolandNuclear Medicne Department Medical University of Warsaw
May 29, 2023
2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
Recruiting
- Glioma
- +4 more
- intraoperative ultrasound
-
Valladolid, SpainUniversity Hospital Rio Hortega
May 16, 2023
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Glioma, Malignant Trial in Rom, Rome (histopathological analysis; morphological and non-morphological magnetic resonance)
Completed
- Glioma, Malignant
- histopathological analysis; morphological and non-morphological magnetic resonance
-
Rom, Roma, Italy
- +1 more
Mar 28, 2023
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Social Cognition and Language in Patients With Gliomas
Not yet recruiting
- Glioma, Malignant
- Cognitive Dysfunction
- Neuropsychological tests
- (no location specified)
Mar 9, 2023
Glioma, Malignant Trial in United States (biological, drug, radiation, other)
Active, not recruiting
- Glioma, Malignant
- AdV-tk
- +5 more
-
Los Angeles, California
- +7 more
Jan 30, 2023
Standard Radiotherapy and TMZ Patients With GBM
Not yet recruiting
- Glioblastoma
- Glioma, Malignant
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 20, 2023
Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))
Recruiting
- Astrocytoma
- +2 more
- temporally-modulated pulsed radiotherapy (TMPRT)
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)
Not yet recruiting
- Glioma, Malignant
- Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
- Hiltonol
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023
Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)
Recruiting
- Glioma
- +4 more
- 18F-Fluciclovine PET-MRI
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2022
Glioma, Malignant, Computer-Assisted Surgery Trial in Shanghai
Active, not recruiting
- Glioma, Malignant
- Computer-Assisted Surgery
-
Shanghai, Shanghai, ChinaFudan University
Dec 16, 2022
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)
Recruiting
- Low-grade Glioma
- +4 more
- Niraparib
- Resection/Treatment with Niraparib
-
Boston, MassachusettsMassachusetts General Hospital
Oct 19, 2022
Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep
Recruiting
- Glioma, Malignant
- +2 more
- NeoPep Vaccine1 plus Poly-ICLC
- NeoPep Vaccine2 plus Poly-ICLC
-
Shanghai, Shanghai, ChinaShanghai 10th People's Hospital
Oct 7, 2022
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
Mapping of Tumor Stem Cells in Resection Marigin During
Recruiting
- Glioma, Malignant
- GlioStem
-
Stockholm, SwedenKarolinska University Hospital
Sep 22, 2022